Campos Daiana, Ravagnani Felipe G, Gurgueira Sonia A, Vercesi Anibal E, Teixeira Simone A, Costa Soraia K P, Muscará Marcelo N, Ferreira Heloisa H A
Laboratory of Inflammation Research, São Leopoldo Mandic Institute and Research Center, Campinas, Sao Paulo, Brazil.
Laboratory of Bioenergetics, Department of Clinical Pathology, Faculty of Medical Sciences, State University of Campinas, Campinas, SP, Brazil.
Int Immunopharmacol. 2016 Oct;39:57-62. doi: 10.1016/j.intimp.2016.07.009. Epub 2016 Jul 15.
The interaction between nitric oxide (NO) and hydrogen sulfide (H2S) in the airways could have significant implications for the pathogenesis and therapeutic effects of both on lung diseases. In this study we investigated whether the beneficial effects of H2S on asthma could be comparable to that inhibition of inducible NO synthase (iNOS).
Female BALB/C mice sensitized with ovalbumin (OVA) received either the H2S donor sodium hydrosulfide (NaHS, 14μmol/kg) or the iNOS inhibitor 1400W (1mg/kg), 30min before each OVA challenge during six days. On the first, second and sixth days, the leucocyte infiltration in lung parenchyma and bronchoalveolar lavage was evaluated. The aconitase activity (a sensor of O2 formation) and lipid peroxidation, as well as levels of reduced glutathione (GSH) and oxidized glutathione (GSSG) were determined in the lung tissues.
OVA-challenge caused a significant and time-dependent increase in the eosinophil number in the airways, which was accompanied by a significant decrease of aconitase activity and GSH/GSSG ratio along with enhanced lipid peroxidation in the lungs. Treatment with NaHS or 1400W significantly attenuated the airways eosinophilia that was paralleled by an increase in aconitase activity and decrease of lipid peroxidation. NaHS or 1400W treatments also reversed the decreased GSH/GSSG ratio seen after OVA-challenge.
The present study shows for the first time that the increased GSH/GSSG ratio caused by either H2S supplementation or iNOS-inhibition is a potential mechanism protecting airways against oxidative stress and inflammatory lung diseases.
气道中一氧化氮(NO)与硫化氢(H₂S)之间的相互作用可能对肺部疾病的发病机制和两者的治疗效果具有重要意义。在本研究中,我们调查了H₂S对哮喘的有益作用是否与抑制诱导型一氧化氮合酶(iNOS)相当。
用卵清蛋白(OVA)致敏的雌性BALB/C小鼠在为期六天的每次OVA激发前30分钟,接受硫化氢供体硫氢化钠(NaHS,14μmol/kg)或iNOS抑制剂1400W(1mg/kg)。在第一天、第二天和第六天,评估肺实质和支气管肺泡灌洗中的白细胞浸润情况。测定肺组织中的乌头酸酶活性(O₂生成的传感器)、脂质过氧化以及还原型谷胱甘肽(GSH)和氧化型谷胱甘肽(GSSG)的水平。
OVA激发导致气道中嗜酸性粒细胞数量显著且呈时间依赖性增加,同时伴有肺中乌头酸酶活性和GSH/GSSG比值显著降低以及脂质过氧化增强。用NaHS或1400W治疗可显著减轻气道嗜酸性粒细胞增多,同时伴有乌头酸酶活性增加和脂质过氧化减少。NaHS或1400W治疗还逆转了OVA激发后出现的GSH/GSSG比值降低。
本研究首次表明,补充H₂S或抑制iNOS所导致的GSH/GSSG比值升高是保护气道免受氧化应激和炎症性肺部疾病影响的潜在机制。